Recent success with targeted therapies to treat benign connective tissue tumours has thrown up important questions, says Professor David Thomas from the Garvan Institute of Medical Research. Using targeted therapies in this way is a completely different scenario to the traditional use in malignant tumours of the connective tissue, he says. “It’s requiring us to ...
Benign tumours a growing problem
By Jennie James
24 Aug 2015